(Q35553680)

8 August 2017

1 reference

title

The German etanercept registry for treatment of juvenile idiopathic arthritis (English)

1 reference

juvenile rheumatoid arthritis

8 August 2017

main subject

1 reference

G Horneff

1

1 reference

8 August 2017

H Schmeling

2

1 reference

8 August 2017

T Biedermann

3

1 reference

8 August 2017

I Foeldvari

4

1 reference

8 August 2017

G Ganser

5

1 reference

8 August 2017

H J Girschick

6

1 reference

8 August 2017

T Hospach

7

1 reference

8 August 2017

H I Huppertz

8

1 reference

8 August 2017

R Keitzer

9

1 reference

8 August 2017

R M Küster

10

1 reference

8 August 2017

H Michels

11

1 reference

8 August 2017

D Moebius

12

1 reference

8 August 2017

B Rogalski

13

1 reference

8 August 2017

A Thon

14

1 reference

8 August 2017

Paediatric Rheumatology Collaborative Group

15

1 reference

8 August 2017

language of work or name

English

0 references

publication date

28 April 2004

1 reference

Annals of the Rheumatic Diseases

8 August 2017

published in

1 reference

8 August 2017

volume

63

1 reference

8 August 2017

issue

12

1 reference

8 August 2017

page(s)

1638-1644

1 reference

Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754849

Therapeutic use of etanercept in polyarticular course juvenile idiopathic arthritis over a two year period

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754849

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754849

Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754849

A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754849

Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754849

Tumor necrosis factor identified in multiple sclerosis brain

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754849

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754849

Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754849

Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754849

Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754849

Onset of multiple sclerosis associated with anti-TNF therapy

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754849

Etanercept therapy in children with treatment-resistant uveitis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754849

Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathy.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754849

Prognosis in children with rheumatic diseases: justification for consideration of new therapies

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1754849

Preliminary criteria for clinical remission in rheumatoid arthritis

26 September 2018

1 reference

12 December 2020

Measurement of health status in children with juvenile rheumatoid arthritis

1 reference

12 December 2020

Preliminary definition of improvement in juvenile arthritis

1 reference

12 December 2020

Juvenile chronic arthritis

1 reference

12 December 2020

Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997

1 reference

12 December 2020

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

12 December 2020

[Recommendations by the Pediatric and Adolescent Rheumatology Study Committee on therapy with Etanercept (p75 TNF-alpha receptor immunoglobulin fusion protein. Pharmacotherapy Committee]

1 reference

12 December 2020

Clinical response to etanercept in polyarticular course juvenile rheumatoid arthritis

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.2003.014886

1 reference

8 August 2017

1 reference

8 August 2017

1 reference